Anemia With Erythropoietin Deficiency Occurs Early in Diabetic Nephropathy
Anemia With Erythropoietin Deficiency Occurs Early in Diabetic Nephropathy Deborah R. Bosman , MBBS 1 , Andrea S. Winkler , MBBS 1 , Joanne T. Marsden , PHD 2 , Iain C. Macdougall , MD 3 and Peter J. Watkins , MD 1 1 King’s Diabetes Centre 2 Department of Biochemistry, and the 3 Department of Renal...
Gespeichert in:
Veröffentlicht in: | Diabetes care 2001-03, Vol.24 (3), p.495-499 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Anemia With Erythropoietin Deficiency Occurs Early in Diabetic Nephropathy
Deborah R. Bosman , MBBS 1 ,
Andrea S. Winkler , MBBS 1 ,
Joanne T. Marsden , PHD 2 ,
Iain C. Macdougall , MD 3 and
Peter J. Watkins , MD 1
1 King’s Diabetes Centre
2 Department of Biochemistry, and the
3 Department of Renal Medicine, King’s College Hospital, London, U.K.
Abstract
OBJECTIVE —The normochromic normocytic anemia of erythropoietin (EPO) deficiency is recognized in advanced renal failure but not in
early renal disease. The aim of this study was to determine whether anemia with EPO deficiency is found in type 1 diabetic
patients with diabetic nephropathy in the absence of advanced renal failure and to compare them with patients with nondiabetic
renal disease of similar severity.
RESEARCH DESIGN AND METHODS —A total of 27 type 1 diabetic patients with diabetic nephropathy (DN), defined as having persistent proteinuria (mean 1,086
mg/day [CI 120–5,190]), a serum creatinine ≤180 μmol/l, and retinopathy, were compared with 26 nondiabetic patients with glomerulonephritis
(GN) and persistent proteinuria (1,874 mg/day [349–5,005]). The Hb concentration, red cell indexes, and serum EPO levels were
measured, and other causes for the anemia were excluded. The EPO values were compared with a normal reference range obtained
from nondiabetic patients with a microcytic anemia. The DN patients were tested for signs of diabetic peripheral and autonomic
neuropathy.
RESULTS —We found that 13 of the 27 DN patients were anemic (Hb 10.6 ± 0.9 g/dl) in marked contrast to none of the GN patients (Hb
13.7 ± 1.4 g/dl, P < 0.005). In the DN group, serum EPO concentrations failed to increase in response to anemia compared with the response seen
in patients with microcytic anemia. Thus, the anemia of the DN group was associated with EPO deficiency. The anemic DN patients
showed evidence of more severe proteinuria and diabetic neuropathy than the nonanemic DN patients.
CONCLUSIONS —Anemia associated with EPO deficiency can occur early in DN before the onset of advanced renal failure, but does not normally
occur in nondiabetic renal disease of similar severity. The pathogenesis requires elucidation.
DN, diabetic nephropathy
EPO, erythropoietin
GN, glomerulonephritis
PH, postural hypotension
Footnotes
Address correspondence and reprint requests to Dr. Peter J. Watkins, King’s Diabetes Centre, King’s College Hospital, Denmark
Hill, London SE5 9RS, U.K. E-mail: peter.watkins1{at}virgin.net .
Received f |
---|---|
ISSN: | 0149-5992 1935-5548 |
DOI: | 10.2337/diacare.24.3.495 |